» Articles » PMID: 31055770

Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2019 May 6
PMID 31055770
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aging plays a significant role in the progression of vascular diseases and vascular dysfunction. Activation of the ADP-ribosylation factor 6 and small GTPases by inflammatory signals may cause vascular permeability and endothelial leakage. Pro-inflammatory molecules have a significant effect on smooth muscle cells (SMC). The migration and proliferation of SMC can be promoted by tumor necrosis factor alpha (TNF-α). TNF-α can also increase oxidative stress in SMCs, which has been identified to persuade DNA damage resulting in apoptosis and cellular senescence. Peroxisome proliferator-activated receptor (PPAR) acts as a ligand-dependent transcription factor and a member of the nuclear receptor superfamily. They play key roles in a wide range of biological processes, including cell differentiation and proliferation, bone formation, cell metabolism, tissue remodeling, insulin sensitivity, and eicosanoid signaling. The PPARγ activation regulates inflammatory responses, which can exert protective effects in the vasculature. In addition, loss of function of PPARγ enhances cardiovascular events and atherosclerosis in the vascular endothelium. This appraisal, therefore, discusses the critical linkage of PPARγ in the inflammatory process and highlights a crucial defensive role for endothelial PPARγ in vascular dysfunction and disease, as well as therapy for vascular aging.

Citing Articles

Quantitative assessment of the association between TNF-α gene polymorphisms and angina risk.

Xu S, Zhou J, Zhang Y Am J Transl Res. 2024; 16(10):5776-5786.

PMID: 39544758 PMC: 11558400. DOI: 10.62347/YXRF7966.


Oxidative Stress Responses in Obese Individuals Undergoing Bariatric Surgery: Impact on Carcinogenesis.

Ribeiro D, Silva G, Malacarne I, Pisani L, Salvadori D Pathophysiology. 2024; 31(3):352-366.

PMID: 39051223 PMC: 11270384. DOI: 10.3390/pathophysiology31030026.


FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway.

Heng Y, Wei W, Cheng L, Wu F, Dong H, Li J Acta Biochim Biophys Sin (Shanghai). 2024; 56(6):892-904.

PMID: 38733164 PMC: 11214975. DOI: 10.3724/abbs.2024032.


Nordic diet and its benefits in neurological function: a systematic review of observational and intervention studies.

Jafari R, Behrouz V Front Nutr. 2023; 10:1215358.

PMID: 37645628 PMC: 10461010. DOI: 10.3389/fnut.2023.1215358.


Extracellular Vesicles and Their Zeta Potential as Future Markers Associated with Nutrition and Molecular Biomarkers in Breast Cancer.

Mendivil-Alvarado H, Limon-Miro A, Carvajal-Millan E, Lizardi-Mendoza J, Mercado-Lara A, Coronado-Alvarado C Int J Mol Sci. 2023; 24(7).

PMID: 37047783 PMC: 10094966. DOI: 10.3390/ijms24076810.


References
1.
Marx N, Bourcier T, Sukhova G, Libby P, Plutzky J . PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999; 19(3):546-51. DOI: 10.1161/01.atv.19.3.546. View

2.
Su C, Wen X, Bailey S, Jiang W, Rangwala S, Keilbaugh S . A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest. 1999; 104(4):383-9. PMC: 408529. DOI: 10.1172/JCI7145. View

3.
Jackson S, Parhami F, Xi X, Berliner J, Hsueh W, Law R . Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999; 19(9):2094-104. DOI: 10.1161/01.atv.19.9.2094. View

4.
Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters J, Gonzalez F . Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999; 274(45):32048-54. DOI: 10.1074/jbc.274.45.32048. View

5.
Barroso I, Gurnell M, Crowley V, Agostini M, Schwabe J, Soos M . Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 2000; 402(6764):880-3. DOI: 10.1038/47254. View